Familial Cold Autoinflammatory Syndrome - 17 Studies Found
Completed |
: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) :
|
Completed |
: The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy : Dental Pulp Exposure : 2005-09-13 :
|
Completed |
: Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer : Unspecified Adult Solid Tumor, Protocol Specific : 2003-04-07 : Biological: CEA peptide 1-6D CAP-1(6D) peptide-pulsed, matured, autologous human DC produced by the Aast |
Terminated |
: Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract :
|
Completed |
: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada : Cryopyrin Associated Periodic Syndrome : 2010-03-25 : Drug: canakinumab (company code: ACZ885D) |
Completed |
: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients :
|
Terminated |
: HL2351 CAPS Phase II Study : Cryopyrin‑Associated Periodic Syndromes (CAPS) : 2016-05-10 : Drug: HL2351 The dose will be adjusted based on disease activities |